Melanoma Protocols

1. CTSU E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon á-2b for Resected High-risk Melanoma
   PI: Maria Constantinou, MD
   Sites: Rhode Island Hospital, The Miriam Hospital

2. BrUOG 275: Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer, and Renal Cancer: A Phase II Brown University Oncology Study
   PI: Maria Constantinou, MD
   Site: The Miriam Hospital, Rhode Island Hospital